The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report

Mayu Morita, Seiji Asoda, Kazuyuki Tsunoda, Tomoya Soma, Taneaki Nakagawa, Masayori Shirakawa, Hirofumi Shoji, Hisao Yagishita, Takeji Nishikawa, Hiromasa Kawana

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Oral lichen planus is a chronic inflammatory mucocutaneous disease. Topical use of steroids and other immuno-modulating therapies have been tried for this intractable condition. Nowadays, tacrolimus ointment is used more commonly as a choice for treatment. However, a number of discussions have taken place after tacrolimus was reported to be carcinogenic. This report describes a patient who applied tacrolimus ointment to the lower lip after being diagnosed with oral lichen planus in 2008, and whose lesion developed squamous cell carcinoma in 2010. Since the relationship between tacrolimus and cancer development has been reported in only a few cases, including this case report, the clinician must be careful selecting tacrolimus as a second-line treatment for oral lichen planus.

Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalOdontology / the Society of the Nippon Dental University
DOIs
Publication statusAccepted/In press - 2016 Jul 1

Fingerprint

Oral Lichen Planus
Tacrolimus
Carcinoma
Ointments
Therapeutics
Lip
Squamous Cell Carcinoma
Steroids
Neoplasms

Keywords

  • Lip
  • Oral lichen planus
  • Squamous cell carcinoma
  • Tacrolimus

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus : a case report. / Morita, Mayu; Asoda, Seiji; Tsunoda, Kazuyuki; Soma, Tomoya; Nakagawa, Taneaki; Shirakawa, Masayori; Shoji, Hirofumi; Yagishita, Hisao; Nishikawa, Takeji; Kawana, Hiromasa.

In: Odontology / the Society of the Nippon Dental University, 01.07.2016, p. 1-5.

Research output: Contribution to journalArticle

@article{143e68e601dd44a9983257f897e1ca96,
title = "The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report",
abstract = "Oral lichen planus is a chronic inflammatory mucocutaneous disease. Topical use of steroids and other immuno-modulating therapies have been tried for this intractable condition. Nowadays, tacrolimus ointment is used more commonly as a choice for treatment. However, a number of discussions have taken place after tacrolimus was reported to be carcinogenic. This report describes a patient who applied tacrolimus ointment to the lower lip after being diagnosed with oral lichen planus in 2008, and whose lesion developed squamous cell carcinoma in 2010. Since the relationship between tacrolimus and cancer development has been reported in only a few cases, including this case report, the clinician must be careful selecting tacrolimus as a second-line treatment for oral lichen planus.",
keywords = "Lip, Oral lichen planus, Squamous cell carcinoma, Tacrolimus",
author = "Mayu Morita and Seiji Asoda and Kazuyuki Tsunoda and Tomoya Soma and Taneaki Nakagawa and Masayori Shirakawa and Hirofumi Shoji and Hisao Yagishita and Takeji Nishikawa and Hiromasa Kawana",
year = "2016",
month = "7",
day = "1",
doi = "10.1007/s10266-016-0255-4",
language = "English",
pages = "1--5",
journal = "Odontology / the Society of the Nippon Dental University",
issn = "1618-1247",
publisher = "Springer Japan",

}

TY - JOUR

T1 - The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus

T2 - a case report

AU - Morita, Mayu

AU - Asoda, Seiji

AU - Tsunoda, Kazuyuki

AU - Soma, Tomoya

AU - Nakagawa, Taneaki

AU - Shirakawa, Masayori

AU - Shoji, Hirofumi

AU - Yagishita, Hisao

AU - Nishikawa, Takeji

AU - Kawana, Hiromasa

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Oral lichen planus is a chronic inflammatory mucocutaneous disease. Topical use of steroids and other immuno-modulating therapies have been tried for this intractable condition. Nowadays, tacrolimus ointment is used more commonly as a choice for treatment. However, a number of discussions have taken place after tacrolimus was reported to be carcinogenic. This report describes a patient who applied tacrolimus ointment to the lower lip after being diagnosed with oral lichen planus in 2008, and whose lesion developed squamous cell carcinoma in 2010. Since the relationship between tacrolimus and cancer development has been reported in only a few cases, including this case report, the clinician must be careful selecting tacrolimus as a second-line treatment for oral lichen planus.

AB - Oral lichen planus is a chronic inflammatory mucocutaneous disease. Topical use of steroids and other immuno-modulating therapies have been tried for this intractable condition. Nowadays, tacrolimus ointment is used more commonly as a choice for treatment. However, a number of discussions have taken place after tacrolimus was reported to be carcinogenic. This report describes a patient who applied tacrolimus ointment to the lower lip after being diagnosed with oral lichen planus in 2008, and whose lesion developed squamous cell carcinoma in 2010. Since the relationship between tacrolimus and cancer development has been reported in only a few cases, including this case report, the clinician must be careful selecting tacrolimus as a second-line treatment for oral lichen planus.

KW - Lip

KW - Oral lichen planus

KW - Squamous cell carcinoma

KW - Tacrolimus

UR - http://www.scopus.com/inward/record.url?scp=84976472747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976472747&partnerID=8YFLogxK

U2 - 10.1007/s10266-016-0255-4

DO - 10.1007/s10266-016-0255-4

M3 - Article

C2 - 27368962

AN - SCOPUS:84976472747

SP - 1

EP - 5

JO - Odontology / the Society of the Nippon Dental University

JF - Odontology / the Society of the Nippon Dental University

SN - 1618-1247

ER -